Tranexamic Acid Injection
- Packing: 5 Ml Ampoule.
- Available Strength : 100 Mg/Ml
Description
Product Description: Tranexamic Acid Injection is a meticulously formulated pharmaceutical solution designed to control and prevent excessive bleeding in various clinical settings. It contains tranexamic acid, an antifibrinolytic agent that inhibits the breakdown of blood clots and reduces bleeding. Manufactured to the highest quality standards, this injection offers effective hemostasis and improved patient outcomes in bleeding disorders and surgical procedures.
Indications and Usage: Tranexamic Acid Injection is indicated for the treatment and prevention of excessive bleeding in patients with hemophilia, von Willebrand disease, or other clotting disorders. It is also used to reduce blood loss and the need for transfusions during surgical procedures, particularly in orthopedic, cardiac, and gynecological surgeries.
Dosage and Administration: The dosage of Tranexamic Acid Injection varies depending on the patient's age, weight, and the severity of bleeding or surgical procedure. It is typically administered via intravenous infusion or injection under the supervision of a qualified healthcare professional. The dosage regimen may involve loading doses followed by maintenance infusions, as determined by the treating physician.
Dosage Forms and Strengths: Tranexamic Acid Injection is available as a sterile solution in vials containing specific concentrations of tranexamic acid formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to tranexamic acid or any of the excipients. It should not be used in patients with active thromboembolic disease, renal impairment, or subarachnoid hemorrhage. Additionally, it is contraindicated in patients with a history of venous or arterial thrombosis.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Tranexamic Acid Injection to patients with a history of thromboembolic events or renal dysfunction. Rarely, serious adverse effects such as thrombosis, seizures, or hypersensitivity reactions may occur. Patients should be monitored closely for signs of these adverse effects during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Tranexamic Acid Injection include nausea, vomiting, and diarrhea. Rarely, serious adverse effects such as thromboembolism, seizures, or allergic reactions may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Tranexamic Acid Injection with other antifibrinolytic agents or drugs that increase the risk of thrombosis may potentiate the anticoagulant effects of tranexamic acid. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Tranexamic Acid Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Tranexamic Acid Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
